Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
31,941
Total Claims
$3.7M
Drug Cost
730
Beneficiaries
$5,007
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+255%
Cost per patient vs peers
$5,007 vs $1,411 avg
+75%
Brand preference vs peers
18.6% vs 10.6% avg
Brand vs Generic
Brand: 5,828 claims · $2.9M
Generic: 25,533 claims · $719K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 1,740 | $715K |
| Empagliflozin | 382 | $304K |
| Diclofenac Epolamine | 429 | $286K |
| Linaclotide | 377 | $233K |
| Dapagliflozin Propanediol | 316 | $227K |
| Semaglutide | 145 | $166K |
| Sitagliptin Phosphate | 200 | $137K |
| Tenofovir Alafenamide | 60 | $87K |
| Budesonide/Glycopyr/Formoterol | 107 | $80K |
| Icosapent Ethyl | 218 | $76K |
| Esomeprazole Magnesium | 748 | $70K |
| Denosumab | 38 | $65K |
| Dexlansoprazole | 261 | $63K |
| Rivaroxaban | 82 | $60K |
| Linagliptin | 83 | $51K |
Prescribing Profile
Patient Profile
73
Avg Age
50%
Female
0.96
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data